“We look forward to seeing the achievements of the UF CTSI and the UF-FSU CTSA hub under Dr. Mitchell’s leadership,” said David R. Nelson, M.D., senior vice president for health affairs at UF & president, UF Health. Nelson had served as CTSI director and CTSA principal investigator since 2010. “We will continue our enthusiastic support of this vital catalyst of resources, people and ideas across UF’s 16 colleges, the state and the nation,” Nelson said.
Betsy Shenkman, Ph.D., remains co-director of the CTSI and co-principal investigator of the CTSA. Awards for the CTSA KL2 career development program for early career faculty and CTSA TL1 training program for Ph.D. students are led, respectively, by principal investigators Thomas A. Pearson, M.D., M.P.H., Ph.D., and Wayne T. McCormack, Ph.D., both professors in the UF College of Medicine.
At FSU, the partnership is led by Jeffrey N. Joyce, Ph.D., senior associate dean for research and graduate programs at the College of Medicine.
“The next four years will be an exciting time for our partnership,” Joyce said. “We look forward to working with Dr. Mitchell to improve the health of our region and the state, particularly in our rural communities.”
Mitchell is co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy and co-leader of the Cancer Therapeutics and Host Response Program at the UF Health Cancer Center. He is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery and the State of Florida Endowed Cancer Research Chair at the UF College of Medicine.